Press release
Mitre Medical Corp. Clinical Data to be Presented Today at EACTS, Including the Introduction and Demonstration of our New Mitral Valve Sizers.
His presentation, “Epicardial Annuloplasty: Introducing a Beating Heart Option for Surgical FMR Repair,” will occur today at 12:15 pm during the New Technology Meets Common Practice session (room location: Auditorium). Prof. Kallenbach will also present 6-month follow-up results from the ENRAPT MR Trial for Epicardial Annuloplasty Repair during the New Solutions in Mitral Repair session on Friday the 19th of October at 15:41 pm (room location: Michelangelo Room).
“We have anticipated the 6-month follow-up to answer fundamental questions of durability of the Mitral Touch. These patients have very large hearts and were in great need, not only for bypass surgery, but also some relief of their MR. We are proud to have Prof. Kallenbach share these results with the cardiac surgery community. Cardiac surgeons and their patients deserve less invasive options like the Mitral Touch to address functional mitral regurgitation.”, commented John MacMahon, CEO of Mitre Medical Corp.
About Mitre Medical Corp.
Mitre Medical Corp. is a medical device company with headquarters in Silicon Valley. The focus of the company is the development of innovative solutions to treat structural heart disease, including the Mitral Touch® device. The Mitral Touch device is currently not approved by the FDA and is not CE marked. The Mitral Touch Sizers are cardiac surgical tools and are presently in physician preference testing in the US.
Mitre Medical Corp.
John MacMahon, CEO
Madrone Pkwy Suite 180
Morgan Hill, CA 95037
USA
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Mitre Medical Corp. Clinical Data to be Presented Today at EACTS, Including the Introduction and Demonstration of our New Mitral Valve Sizers. here
News-ID: 1312423 • Views: …
More Releases from Mitre Medical Corp.
Mitre Medical Corp.: Mitre Medical Corp, is proud to be an Exhibitor at the upco …
Silicon Valley, March 29, 2019 – Mitre Medical Corp. announces the participation the STS Workshop on Robotic Cardiac Surgery in Atlanta, Georgia. The course will offer extensive hands-on procedural experience in a state-of-the-art robotics training facility. Specially designed for surgical teams, the event will put participants in a realistic, cardiac robotics simulation environment where they can hone their skills in mitral valve repair, coronary bypass, and other cardiac surgery procedures.
“We…
Mitre Medical Corp.: Mitre Medical Corp. Strengthens Its Team with New Strategic …
Silicon Valley, April 17, 2018 – Mitre Medical Corp. announces successful recruitment of experienced cardiac surgery business executive Maria Sainz as a Strategic Advisor. Ms. Sainz brings more than two decades of medical device industry experience most recently as President and CEO of CardioKinetix. Notable among prior senior leadership roles, she served as President of Guidant’s Cardiac Surgery Division from 2003 through 2006 and as CEO of Concentric Medical.
“We are…
Mitre Medical Corp.: Completion of the feasibility phase for the Mitral Touch® …
Silicon Valley, 03/28/2018 – Mitre Medical Corp. announces completion of the feasibility phase of the Study of the Mitral Touch System for the Reduction of Mitral Valve Regurgitation (the EnraptMR Trial). Treatment with the Mitral Touch implant has demonstrated safety and technical success including durability of MR reduction at 30 days.
“Validation of durable MR reduction on the beating hearts of these challenging patients is a real milestone for…
More Releases for Mitral
Impact Of Rising Prevalence Of Vascular Heart Diseases On The Mitral Valve Disea …
What industry-specific factors are fueling the growth of the mitral valve disease market?
The growing prevalence of vascular heart diseases is expected to boost the mitral valve disease market. Vascular heart diseases, including ischemic heart disease and hypertension, can lead to mitral valve disease by affecting the heart's structure and function. The Australian Bureau of Statistics reported an increase in cardiovascular disease-related deaths from 2021 to 2022, indicating the rising incidence…
Impact Of Rising Prevalence Of Vascular Heart Diseases On The Mitral Valve Disea …
What Are the Projected Growth and Market Size Trends for the Mitral Valve Disease Market?
In the past few years, the market size for mitral valve disease has seen a formidable growth. It is projected to increase from $3 billion in 2024 to $3.3 billion in 2025, with a compound annual growth rate (CAGR) of 9.8%. The historic growth can be credited to efforts in patient education, robust reimbursement policies and…
Emerging Therapies and Innovations in Mitral Valve Disease Market
Mitral valve disease, a prevalent cardiovascular disorder, presents a significant health burden worldwide. As medical science advances, a wave of innovative therapies and technologies is reshaping the landscape of mitral valve disease treatment. This report delves into the latest breakthroughs, therapies, and interventions that are driving the evolution of the mitral valve disease market. By examining emerging trends, clinical trials, and advancements, this report offers a comprehensive analysis of the…
Transcatheter Mitral Valve Replacement Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Transcatheter Mitral Valve Replacement Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 124 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.
Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/global-transcatheter-mitral-valve-replacement-tmvr-market_p104117.html
Mitral valve is located on the…
Transcatheter Mitral Valve Repair & Replacement Market - Evolution in Geriatric …
The Transcatheter Mitral Repair and Replacement Market is expected to reach $ 1,878 million (both repair and replacement valves) by 2023, with a CAGR of 30.0% from 2017 to 2023. Mechanical valve segments accounted for the largest share of the entire market in 2016.
The mitral valve is a heart valve that sends blood from one chamber of the heart to the left atrium to another valve called the left ventricle.…
Global Transcatheter Mitral Valve Replacement Sales Market Report 2017
MarketResearchReports.Biz presents this most up-to-date research on "Global Transcatheter Mitral Valve Replacement Sales Market Report 2017"
Description
This report studies sales (consumption) of Transcatheter Mitral Valve Replacement in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Abbott Laboratories
Edwards Lifesciences
Micro Interventional Devices
Neovasc
MitrAssist
NaviGate Cardiac Structures
Valtech
...
Market Segment by Regions, this report splits Global…
